DK0642796T3 - Levende Salmonella-vaccine - Google Patents

Levende Salmonella-vaccine

Info

Publication number
DK0642796T3
DK0642796T3 DK93114221T DK93114221T DK0642796T3 DK 0642796 T3 DK0642796 T3 DK 0642796T3 DK 93114221 T DK93114221 T DK 93114221T DK 93114221 T DK93114221 T DK 93114221T DK 0642796 T3 DK0642796 T3 DK 0642796T3
Authority
DK
Denmark
Prior art keywords
salmonella vaccine
marker
host
live salmonella
live vaccine
Prior art date
Application number
DK93114221T
Other languages
Danish (da)
English (en)
Inventor
Klaus Prof Dr Linde
Joerg Dr Beer
Baerbel Dipl-Ing Randhagen
Original Assignee
Lohmann Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Animal Health Gmbh filed Critical Lohmann Animal Health Gmbh
Application granted granted Critical
Publication of DK0642796T3 publication Critical patent/DK0642796T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0275Salmonella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93114221T 1993-09-04 1993-09-04 Levende Salmonella-vaccine DK0642796T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93114221A EP0642796B1 (de) 1993-09-04 1993-09-04 Salmonella-Lebendimpfstoff

Publications (1)

Publication Number Publication Date
DK0642796T3 true DK0642796T3 (da) 2002-01-21

Family

ID=8213234

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93114221T DK0642796T3 (da) 1993-09-04 1993-09-04 Levende Salmonella-vaccine

Country Status (14)

Country Link
EP (1) EP0642796B1 (ru)
JP (1) JP2838098B2 (ru)
CN (1) CN1097466C (ru)
AT (1) ATE209929T1 (ru)
AU (1) AU687861B2 (ru)
BR (1) BR9405578A (ru)
CA (1) CA2131231C (ru)
DE (3) DE10299020I2 (ru)
DK (1) DK0642796T3 (ru)
ES (1) ES2168265T3 (ru)
NL (1) NL300092I2 (ru)
PT (1) PT642796E (ru)
RU (1) RU2177804C2 (ru)
WO (1) WO1995007101A2 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136325A (en) * 1993-04-09 2000-10-24 Lohmann Animal Health Gmbh & Co. Kg Live vaccine constituting minor risk for humans
DE202004006282U1 (de) 2004-04-19 2004-07-01 Lohmann Animal Health Gmbh & Co. Kg Vorrichtung für die Empfindlichkeitsprüfung bakterieller Infektionserreger und Impfstämme des Geflügels
DE102007012824A1 (de) * 2007-03-17 2008-09-18 Universität Leipzig Impfstämme mit abgestuften Koloniegrößen/Attenuierungen und Verfahren zu deren Isolierung
DE102008062941A1 (de) * 2008-12-23 2010-07-01 Universität Leipzig Impfstämme gegen bakterielle und fungale Infektionen
WO2014037445A1 (en) * 2012-09-05 2014-03-13 Lohmann Animal Health Gmbh Preparation of live vaccines
WO2014037103A1 (en) 2012-09-05 2014-03-13 Universität Leipzig Live attenuated metabolic drift vaccine against fowl typhoid
ES2776429T3 (es) * 2012-12-07 2020-07-30 Elanco Tiergesundheit Ag Preparación de vacunas vivas
RU2750865C1 (ru) * 2020-04-09 2021-07-05 Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук" (ФГБНУ ФНЦ ВИЭВ РАН) Поливалентная инактивированная вакцина против риемереллёза, пастереллёза и сальмонеллёза индеек, уток и гусей, способ её получения

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2843295A1 (de) * 1978-10-04 1980-10-30 Inst Impfstoffe Dessau Verfahren zur herstellung stabiler avirulenter und hochimmunogener bakterienmutanten fuer lebendimpfstoffe
EP0263528B1 (de) * 1986-10-10 1995-12-20 Lohmann Animal Health GmbH & Co. KG Salmonella-Lebendimpfstoffe mit Wirtsspezies-angepassten Attenuierungshöhen und antiepidemischer Potenz

Also Published As

Publication number Publication date
JP2838098B2 (ja) 1998-12-16
CN1097466C (zh) 2003-01-01
BR9405578A (pt) 1999-09-08
WO1995007101A2 (de) 1995-03-16
AU687861B2 (en) 1998-03-05
JPH07206706A (ja) 1995-08-08
DE10299020I2 (de) 2007-12-27
CA2131231A1 (en) 1995-03-05
DE4496626D2 (de) 1996-06-27
EP0642796A1 (de) 1995-03-15
DE59310244D1 (de) 2002-01-17
CA2131231C (en) 1999-01-19
ES2168265T3 (es) 2002-06-16
CN1114100A (zh) 1995-12-27
PT642796E (pt) 2002-05-31
DE10299020I1 (de) 2002-11-07
AU7537494A (en) 1995-03-27
RU95112808A (ru) 1997-03-20
WO1995007101A3 (de) 1995-04-27
EP0642796B1 (de) 2001-12-05
NL300092I2 (nl) 2002-12-02
RU2177804C2 (ru) 2002-01-10
NL300092I1 (nl) 2002-08-01
ATE209929T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
WO2000004919A3 (en) Live attenuated salmonella vaccines to control avian pathogens
MX9201245A (es) Nueva formulacion de vacuna para tratar infecciones cuasadas por el virus de herpes simple.
DE69936877D1 (de) STREPTOKOKKEN-C5a-PEPTIDASE-IMPFSTOFF
ATE209929T1 (de) Salmonella-lebendimpfstoff
DE3586841D1 (de) Orale impfstoffe.
ATE91902T1 (de) Hundecoronavirus-impfstoff.
NZ195184A (en) Live feline infectious peritonitis (fip) virus vaccine; fip virus atcc no.vr-2004
SE7512828L (sv) Calicivirusvaccin
IE44911L (en) Rhinotracheitis vaccine.
ATE270112T1 (de) Streptococcus equi impfstoff
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
PT88592A (pt) Vaccine for protection of cats against feline infections peritonitis
DE3781039D1 (de) Vakzine-zusammensetzung zum immunisieren gegen durch e. coli verursachte harnwegeinfektion.
DE69708425D1 (de) Makrophagen infizierende Parasiten, die ein Leukozyten- und Makrophagen-stimulierendes Hormon exprimieren
DE3788986D1 (de) Geflügelcolibacillose-Vakzin.
DK445987D0 (da) Swalpamycin, fremstilling deraf og dets anvendelsesom laegemiddel, samt ved fremstillingen anvendelig mikroorganisme
ATE84722T1 (de) Tollwut-lebendimpfstoff.
FI864769A (fi) Icke-adjuvanserad vaccin.
Plommet Brucella and brucellosis: An update.